How Long Does Myalept Last?

Generic: METRELEPTIN

3 days
Shelf life from federal drug label data

Storage Conditions

Room temperature Refrigerate Do not freeze Protect from light

Reported Side Effects

From 771 FDA adverse event reports (FAERS). 41.4% classified as serious.

771
Total Reports
41.4%
Serious
15
Side Effects Tracked
Side EffectReports
PRODUCT DOSE OMISSION ISSUE
81
THERAPY CESSATION
78
WEIGHT DECREASED
72
BLOOD GLUCOSE INCREASED
67
THERAPY INTERRUPTED
53
NAUSEA
51
DRUG INEFFECTIVE
43
DECREASED APPETITE
40
INJECTION SITE PAIN
39
WEIGHT INCREASED
39
BLOOD TRIGLYCERIDES INCREASED
33
HEADACHE
33
TREATMENT NONCOMPLIANCE
33
BLOOD GLUCOSE DECREASED
31
HOSPITALISATION
30

Data from FDA Adverse Event Reporting System (FAERS). Reports reflect consumer/provider submissions — higher counts may reflect higher usage, not necessarily higher risk. Not all reports establish a causal link.

Manufacturer

Amryt Pharmaceuticals Designated Activity Company

Storage Information

16.2 Storage and Handling MYALEPT should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) and protected from light until preparing for use. Keep MYALEPT vials in the carton when not in use. MYALEPT should not be used past the expiration date. Do not freeze MYALEPT. Do not use if the white lyophilized cake is discolored. Use with BWFI: when MYALEPT is reconstituted with BWFI, the vial can be used for multiple doses within 3 days when stored in the refrigerator at 36°F to 46°F (2°C to 8°C) and protected from light. Use with WFI: when MYALEPT is reconstituted with WFI, the vial can be used for a single dose should be administered immediately. Unused reconstituted solution cannot be saved for later use and should be discarded. After reconstitution, the vials should not be frozen (below 0°C) or shaken vigorously. If the reconstituted product is inadvertently frozen, it should be thrown away. After reconstitution, the mixture should be clear and colorless. Do not use if visible particulates are present in the solution. Keep out of the reach of children. 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied MYALEPT (metreleptin) for injection for subcutaneous administration is supplied in a single carton containing one vial for reconstitution (NDC 76431-210-01). Each vial contains 11.3 mg metreleptin (as a sterile, white, solid, lyophilized cake) to deliver 5 mg per mL of metreleptin when reconstituted with 2.2 mL of BWFI or WFI. 16.2 Storage and Handling MYALEPT should b

Important: This information is from federal drug label data and is for reference only. Always follow the specific expiration date printed on your medication packaging. Consult your pharmacist or healthcare provider with questions about medication storage or expiration.

Data source: View Myalept on DailyMed (NIH) | Federal drug label data.

Page generated: 2026-03-29